Sickle Cell Disease | Pathophysiology, Symptoms and Treatment

JJ Medicine
2 Apr 201812:55

Summary

TLDRThis video provides an in-depth explanation of sickle cell disease, a hereditary blood disorder characterized by sickle-shaped red blood cells. It covers the genetic basis, where the disease is inherited in an incomplete autosomal dominant fashion, and explains how a point mutation in the hemoglobin beta globin chain leads to the abnormal shape. The pathophysiology, including RBC sickling, hemolysis, and vaso-occlusion, as well as acute and chronic complications such as pain, anemia, and organ damage, are discussed. Diagnosis and treatment options, including hydroxyurea and bone marrow transplants, are also highlighted.

Takeaways

  • 🧬 Sickle cell disease is a hereditary blood disorder characterized by sickle-shaped red blood cells.
  • 🧬 It is inherited in an incomplete autosomal dominant fashion, where individuals with two copies of the affected allele are fully affected.
  • 🧬 People with one affected allele have sickle trait, which offers some protection against malaria but causes less severe symptoms.
  • 🧬 The disease is caused by a single point mutation in the hemoglobin beta-globin chain, substituting glutamic acid with valine at position six.
  • 🔬 Sickle-shaped red blood cells can clog small blood vessels, leading to painful vaso-occlusion and increased risk of organ damage.
  • 🔬 Red blood cells in sickle cell disease have a shorter lifespan (around 17 days) compared to normal red blood cells (120 days).
  • 💉 Acute complications include severe anemia, infections, and pain caused by the sickling of red blood cells during stress conditions like hypoxia and dehydration.
  • 🩺 Chronic complications include hemolytic anemia, chronic pain, delayed growth, and neurological, renal, and cardiovascular issues.
  • 🧪 Sickle cell disease can be diagnosed through prenatal testing, newborn screening, and hemoglobin electrophoresis.
  • 💊 Hydroxyurea is a common treatment that reduces pain episodes and prolongs survival, while bone marrow transplants offer a potential cure for patients under 16.

Q & A

  • What is sickle cell disease?

    -Sickle cell disease is a group of hereditary blood disorders characterized by sickle-shaped red blood cells.

  • How is sickle cell disease inherited?

    -Sickle cell disease is inherited in an incomplete autosomal dominant fashion. Individuals with two copies of the affected allele (homozygous) are fully affected, while those with one copy (heterozygous) are carriers and can be slightly affected.

  • What is the difference between individuals with sickle cell disease and those with sickle cell trait?

    -Individuals with sickle cell disease are homozygous for the hemoglobin S allele, while those with sickle cell trait are heterozygous and experience milder or no symptoms.

  • Why does the sickle cell mutation persist in certain populations?

    -The sickle cell mutation provides protection against malaria, which is why it persists in populations where malaria is prevalent.

  • What causes the abnormal shape of red blood cells in sickle cell disease?

    -A single point mutation on the hemoglobin beta globin chain changes glutamic acid to valine at position six, causing hemoglobin S. When deoxygenated, hemoglobin S is less soluble and aggregates, leading to red blood cell sickling.

  • What complications arise from sickle-shaped red blood cells?

    -Sickle-shaped red blood cells can get trapped in small blood vessels, leading to vascular occlusion, hemolysis, and inflammatory responses, which cause pain, anemia, and other complications.

  • How long do sickle-shaped red blood cells live compared to normal red blood cells?

    -Sickle-shaped red blood cells have a significantly reduced lifespan, living about 10 to 20 days compared to normal red blood cells, which live around 120 days.

  • What are some of the acute complications of sickle cell disease?

    -Acute complications include an increased risk of infections, severe anemia, and vaso-occlusive pain due to sickled red blood cells blocking blood vessels.

  • What are some chronic complications of sickle cell disease?

    -Chronic complications include chronic hemolytic anemia, pain, neurologic deficits, pulmonary issues, renal problems, osteoporosis, cardiomyopathy, delayed growth, and chronic leg ulcers.

  • What treatments are available for sickle cell disease?

    -Treatment options include hydroxyurea, which reduces pain episodes and hospitalizations, blood transfusions for severe anemia, and hematopoietic cell transplantation, which is considered a potential cure for individuals under 16 years old.

Outlines

00:00

🔬 Understanding Sickle Cell Disease

Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells. The condition is inherited in an incomplete autosomal dominant pattern. Individuals with two copies of the affected gene are homozygous and fully affected, while those with one copy are heterozygous carriers (sickle cell trait) with milder symptoms. The mutation has been linked to protection against malaria, which is why it persists in populations where malaria is common.

05:02

🩸 Pathophysiology and Hemoglobin Mutation

The root cause of sickle cell disease lies in a mutation of the beta-globin chain of hemoglobin, where glutamic acid is replaced by valine at position six. This single-point mutation results in the formation of hemoglobin S, which tends to aggregate when deoxygenated, leading to the sickling of red blood cells. These misshapen cells get trapped in the microvasculature, leading to occlusion, hemolysis, and a dramatically shortened lifespan of sickle red blood cells (around 17 days compared to 120 days for normal cells).

10:03

⚠️ Acute and Chronic Complications of Sickle Cell Disease

Patients with sickle cell disease face increased risks of infections and severe anemia due to the sickling of red blood cells. Conditions like fever, dehydration, hypoxia, and acidosis exacerbate the problem. The sickling causes vaso-occlusion, leading to painful episodes, stroke, acute chest syndrome, renal infarction, myocardial infarction, and other complications. Over time, the disease leads to chronic hemolytic anemia, where the body tries to compensate by producing more immature red blood cells (reticulocytes). Blood smears show features like polychromasia and Howell-Jolly bodies.

🩺 Long-term Effects and Diagnostic Approaches

Chronic complications include pain from vaso-occlusion, neurological deficits, pulmonary conditions, renal hypertension, osteoporosis, and more. Diagnosing sickle cell disease involves prenatal testing, newborn screenings, high-performance liquid chromatography, and hemoglobin electrophoresis. A diagnosis is confirmed if more than 30% of hemoglobin is found to be hemoglobin S.

💉 Treatment and Management of Sickle Cell Disease

The main treatments for sickle cell disease include hydroxyurea, which reduces pain episodes, hospitalizations, and improves survival, and bone marrow transplantation, which is considered the only cure and typically performed in patients under 16. Blood transfusions are also used, especially in severe anemia cases. Pain management is crucial to improve the quality of life for affected individuals.

Mindmap

Keywords

💡Sickle-cell disease

Sickle-cell disease is a hereditary blood disorder characterized by the presence of abnormal, sickle-shaped red blood cells. These misshapen cells can cause blockages in blood vessels, leading to complications such as pain, anemia, and increased risk of infection. The disease is discussed throughout the video as a central theme, emphasizing its genetic nature and clinical consequences.

💡Hemoglobin S

Hemoglobin S is a variant form of hemoglobin that causes red blood cells to become misshapen or 'sickled' when deoxygenated. It is the result of a mutation in the beta-globin gene, where glutamic acid is replaced by valine. In individuals with sickle-cell disease, hemoglobin S leads to cell sickling and is less soluble, causing complications such as microvascular blockages.

💡Autosomal incomplete dominance

This refers to the genetic inheritance pattern of sickle-cell disease. Although individuals with two copies of the mutated allele are fully affected, even carriers with one mutated allele (heterozygous) can show mild symptoms, indicating incomplete dominance. This is highlighted to explain why some individuals with only one allele (sickle trait) experience minor effects.

💡Vaso-occlusion

Vaso-occlusion refers to the blockage of small blood vessels by sickled red blood cells. This leads to painful crises and other complications such as stroke and organ damage. The video describes this as one of the major symptoms of sickle-cell disease, particularly during stressful conditions like infection or dehydration.

💡Hemolysis

Hemolysis is the destruction of red blood cells, which occurs in sickle-cell disease due to the abnormal shape of the cells. This leads to anemia, as sickled red blood cells have a significantly reduced lifespan (around 17 days compared to the normal 120 days). Hemolysis is a core issue in the pathophysiology of sickle-cell disease, leading to chronic anemia and other complications.

💡Hydroxyurea

Hydroxyurea is a medication used to reduce the frequency of pain episodes, hospitalizations, and prolong the lifespan of individuals with sickle-cell disease. It is mentioned as a standard treatment option in the video and helps by increasing the production of fetal hemoglobin, which prevents sickling.

💡Bone marrow transplantation

Bone marrow transplantation, also known as hematopoietic stem cell transplantation, is a potential cure for sickle-cell disease. However, it is usually only performed on individuals under 16 years old. This is described in the video as one of the few curative treatments available for sickle-cell disease.

💡Sickle-cell trait

Sickle-cell trait refers to individuals who carry only one copy of the mutated gene (hemoglobin S). While they are usually asymptomatic, they can have mild symptoms under certain conditions. The video explains that about 7-8% of African Americans have this trait, which also provides partial protection against malaria.

💡Microvascular trapping

Microvascular trapping occurs when sickled red blood cells become stuck in small blood vessels, leading to blockages that cause pain, organ damage, and other complications. The video emphasizes this as a key reason for many symptoms of sickle-cell disease, such as pain crises and increased risk of infection.

💡Reticulocytes

Reticulocytes are immature red blood cells that increase in number as the body attempts to compensate for the destruction of sickled red blood cells. The video mentions that patients with sickle-cell disease often have elevated levels of reticulocytes as the bone marrow works to produce more red blood cells to replace the ones being destroyed prematurely.

Highlights

Sickle-cell disease is a group of hereditary blood disorders characterized by sickle-shaped red blood cells.

Sickle-cell disease is inherited in an incomplete autosomal dominant fashion, meaning even carriers with one allele can show mild symptoms.

Individuals homozygous for hemoglobin SS are fully affected by sickle-cell disease, with an estimated prevalence of 1 in 400 to 1 in 600 African Americans.

Carriers with one sickle-cell allele (heterozygous) are referred to as having sickle trait, which affects about 7-8% of African Americans.

The sickle-cell mutation appears to provide protection against malaria, explaining its persistence in populations where malaria is prevalent.

The disease is caused by a single point mutation at position 6 on the beta globin chain of hemoglobin, substituting glutamic acid with valine.

Deoxygenated hemoglobin S is less soluble than normal hemoglobin A, leading to red blood cell sickling during stress, hypoxia, or dehydration.

Sickled red blood cells can occlude small blood vessels, causing microvascular trapping and leading to severe complications like hemolysis and vaso-occlusion.

Sickled red blood cells have a dramatically shortened lifespan, living about 17 days compared to 120 days for normal red blood cells.

Patients with sickle-cell disease are at increased risk of infections, severe anemia, and complications from vaso-occlusion, such as stroke and acute chest syndrome.

Acute complications include infections, anemia, and vaso-occlusive crises, which can lead to severe pain, stroke, and other organ damage.

Chronic complications include hemolytic anemia, pain, neurologic deficits, renal hypertension, osteoporosis, and retinopathy.

Diagnostic methods include prenatal tests, newborn screenings, high-performance liquid chromatography, and hemoglobin electrophoresis.

Hydroxyurea is a common treatment that reduces pain episodes, hospitalizations, and prolongs survival in patients with sickle-cell disease.

Bone marrow or stem cell transplantation is the only potential cure for sickle-cell disease, typically performed in patients under 16 years old.

Transcripts

play00:00

hey everyone and this is we're talking

play00:01

about sickle-cell disease so what is

play00:03

sickle-cell disease well is a group of

play00:05

hereditary blood disorders with

play00:07

characteristic sickle shaped red blood

play00:08

cells so you can see here the cell on

play00:12

the right is a sickle shaped red blood

play00:14

cell and the one on the left is a normal

play00:16

red blood cell now sickle cell disease

play00:20

is inherited and is actually inherited

play00:22

an incomplete autosomal dominant fashion

play00:25

so on the right here in the schematic

play00:27

you can see that an individual an

play00:30

affected individual has two copies

play00:33

they're homozygous so they have two

play00:35

copies of the affected allele so they're

play00:38

considered affected so in individuals

play00:41

with only one allele are considered

play00:43

unaffected carrier so it appears to be

play00:46

recessive condition but in fact even

play00:49

individuals with one of the affected

play00:51

alleles can be can be affected to a very

play00:54

slight degree so that's why we

play00:56

considered incomplete autosomal dominant

play00:59

so as I mentioned again an individual

play01:02

with two copies of hemoglobin s s just

play01:06

standing for the sickle cell disease

play01:07

allele so he below man s s or homozygous

play01:11

these are the affected these are the

play01:14

individuals that are fully affected by

play01:16

sickle cell disease and these homozygous

play01:21

individuals make up about one one in

play01:24

four hundred to one in six hundred

play01:26

african-americans have or are homozygous

play01:30

for sickle-cell disease and the other

play01:35

portion of individuals the individuals

play01:37

with only one affected allele are

play01:38

considered heterozygous and they are

play01:41

considered to have sickle trait so again

play01:43

they're very slightly affected but not

play01:46

as much to the degree as someone that

play01:49

has homozygous hemoglobin s s and

play01:55

individuals with the sick of trade over

play01:57

heterozygous individuals about seven to

play01:59

eight percent of African Americans have

play02:02

sickle trade now the sickle cell

play02:05

mutation appears to be protective

play02:07

against malaria so that's the reason why

play02:10

it seems to be pro our persistent

play02:13

some of the populations where malaria is

play02:15

prevalent so individuals with one allele

play02:18

seems to be the best way to be able to

play02:21

protected against malaria so what is

play02:24

some of the pathophysiology of sickle

play02:26

cell disease well it all has to do with

play02:29

the hemoglobin beta globin chain so the

play02:32

beta globin chain of hemoglobin is

play02:34

affected and this beta globin chain is

play02:38

encoded on chromosome 11 and in sickle

play02:43

cell disease it's actually all due to an

play02:47

amino acid substitution at position six

play02:50

on the bladed globin chain and all it is

play02:52

is a substitution from glutamic acid to

play02:57

valine so there is only a single point

play03:01

mutation changing glutamic acid to

play03:04

valine at position six on the globe beta

play03:08

globin chain and this is what causes the

play03:12

deformed red blood cell shape the

play03:16

problems in sickle cell disease are all

play03:19

just due to a single point mutation and

play03:21

what happens is when this beta globin

play03:25

chain is mutated we considered

play03:28

hemoglobin s and deoxygenated hemoglobin

play03:32

s is less soluble than deoxygenated

play03:35

hemoglobin a the normal hemoglobin so

play03:39

that means that whenever Kim globin is

play03:41

the option in Aidid for some reason it

play03:43

can lead to increased polymerization so

play03:46

that means that hemoglobin s can start

play03:49

to aggregate in accumulate together it

play03:54

leads to RBC sickling so deoxygenated

play03:57

hemoglobin s can lead to RBC sickling

play03:59

and the RBC sickling occurs during

play04:03

conditions of stress and when red blood

play04:09

cells do undergo sickling they can lead

play04:13

to hemolysis and they can lead to

play04:15

occlusion of the vasculature in these

play04:18

individuals and you can think about it

play04:21

if the red blood cells are traveling

play04:24

through different

play04:26

vasculature like capillaries for

play04:29

instance if the cells are misshapen in

play04:33

particular in a sickle shell shape they

play04:36

may get clogged and they may get stuck

play04:38

in certain areas in the vasculature this

play04:40

is what leads to a lot of this occlusion

play04:43

and a lot of symptoms related to sickle

play04:45

cell disease and this is something we

play04:49

call micro vascular trapping and all of

play04:53

this leads to hemo phagocytosis so a lot

play04:57

of times we'll get white blood cells

play04:59

coming in and they will be essentially

play05:01

cleaning up a lot of these red blood

play05:04

cells a lot of these sickle red blood

play05:06

cells and this leads to a dramatically

play05:11

reduced lifespan of sick old red blood

play05:15

cells and in fact it's about 17 days so

play05:19

on average and normal red blood cell

play05:20

lives for about 120 days but a sick old

play05:23

red blood cell can live from anywhere

play05:24

from 10 to 20 days usually about 17 days

play05:28

so again it's because these red blood

play05:31

cells become sickle they get clogged in

play05:33

certain areas specifically in micro

play05:36

vascular areas this can lead to an

play05:39

inflammatory reaction white blood cells

play05:41

can come in and start to phagocytize

play05:43

these red blood cells and that's why you

play05:46

see a dramatically reduced lifespan of

play05:50

cycled red blood cells so what are some

play05:52

of the signs and symptoms of sickle cell

play05:54

disease well some of the acute

play05:57

complications of sickle cell disease are

play05:59

that individuals with sickle cell

play06:01

disease are at an increased risk of

play06:03

infections furthermore because of the

play06:09

sickling of red blood cells these

play06:11

patients can experience severe anemia

play06:14

and again it's because of the sickling

play06:17

of red blood cells and again signaling

play06:20

of the red blood cells occurs during

play06:21

conditions of stress so what are some of

play06:23

those conditions of stress well they can

play06:25

include fever they can include infection

play06:28

they can include dehydration hypoxia and

play06:30

acidosis

play06:31

so anything that leads to a deoxidation

play06:36

or further the oxygenation of hemoglobin

play06:39

s Kenley

play06:40

to sickling of the red blood cells which

play06:42

can lead to complications so again these

play06:48

individuals are at an increased risk of

play06:50

infections and in fact affections can

play06:52

lead to sickling so it's a vicious cycle

play06:54

of sickling and symptoms of the red

play06:59

blood cell cycling when the red blood

play07:01

cells do undergo a sickling they can

play07:05

lead to basal occlusion and a lot of

play07:08

symptoms of sickle cell disease are due

play07:09

to basal occlusion some of them include

play07:13

acute basal occlusive pain so when a lot

play07:17

of these sickle red blood cells get get

play07:20

essentially trapped or occluded within

play07:22

the vasculature it can cause pain it can

play07:25

lead to stroke in some patients there

play07:28

can be acute chest syndrome there can be

play07:30

renal infarction myocardial infarction

play07:33

priapism in venous thromboembolism so

play07:36

anything that can lead to clogging up of

play07:39

vasculature can lead to formation of

play07:42

thrombi mbola emboli can lead to

play07:46

infarction so essentially cutting off

play07:48

the blood supply to certain areas like

play07:50

the kidneys in the heart can all be due

play07:53

to red blood cells being sickle and

play07:57

essentially clogging up those arteries

play07:59

or clogging up those vascular areas so

play08:04

what are some of the chronic

play08:06

complications of sickle cell disease

play08:08

well essentially the biggest

play08:12

complication is chronic compensated

play08:16

hemolytic anemia so chronic compensated

play08:20

chronic it's a long term process

play08:23

compensated the body attempts to

play08:25

compensate because of the chronicity of

play08:28

the anemia and hemolytic anemia

play08:30

hemolytic essentially means the body is

play08:32

destroying the red blood cells and this

play08:35

leads to these individuals essentially

play08:37

having chronically low levels of

play08:39

hemoglobin essentially it's a it's

play08:41

usually these patients can have

play08:43

hemoglobin levels from anywhere from 60

play08:46

to 90 grams per liter the hematocrit is

play08:50

usually low as well at about 20 to 30%

play08:54

these patients when you look at a blood

play08:57

smear the cells can have or the cells

play09:00

can be polychromatic or have

play09:03

polychromasia so when you look at them

play09:05

they can be different colors so on a

play09:07

blood smear you can see here's some

play09:09

normal cells and you can see these other

play09:11

cells that are different colors so

play09:13

that's essentially what polychromasia

play09:14

means these individuals can have

play09:17

reticulocyte ptosis it's about 3 to 15%

play09:20

of blood cells can be reticulocytes

play09:22

reticulocytes are just immature red

play09:24

blood cells so what happens it what is

play09:26

when the body is destroying through that

play09:32

hemophagocytic process you're destroying

play09:35

those sick old red blood cells the body

play09:38

compensates it starts to try to produce

play09:40

more red blood cells and releases more

play09:42

immature red blood cells that's why we

play09:44

see increased levels of reticulocytes

play09:45

and another thing you can see in a blood

play09:48

smear is something called Howell Jolly

play09:50

bodies and how jolly bodies are these

play09:53

basal philic nuclear remnants inside a

play09:58

red blood cell so you can see those as

play10:00

well when you look at a blood smear in

play10:03

other chronic complications include pain

play10:05

usually from the basal occlusion there

play10:08

can be neurologic deficits in some

play10:09

patients pulmonary conditions due to

play10:12

increased risk of infections there can

play10:14

be renal hypertension osteoporosis

play10:17

cardiomyopathy due to diastolic

play10:18

dysfunction hepatic toxicity delayed

play10:21

puberty reduced growth chronic leg

play10:24

ulcers and proliferative retinopathy so

play10:27

not all of these can occur in every

play10:30

patient but some patients can have some

play10:32

of these other complications some of

play10:34

them are due to the basal occlusive

play10:37

properties of sickle red blood cells so

play10:39

pain again due to vaso occlusion due

play10:43

because of pain individuals may not be

play10:47

as active as other individuals so they

play10:49

can have decreased bone mineral density

play10:51

leading to an increased risk of

play10:53

osteoporosis there can be again chronic

play10:58

leg ulcers due to some of these basal

play11:00

occlusive properties as well so how do

play11:02

you diagnose sickle cell disease well

play11:04

there's prenatal tests to deter

play11:07

if a fetus carries sickle-cell alleles

play11:10

there are newborn screenings to do the

play11:13

same thing to see if a newborn infant is

play11:15

carrying a mutated allele for

play11:19

sickle-cell disease high performance

play11:22

liquid chromatography can be performed

play11:24

to assess and also haemoglobin

play11:28

electrophoresis can be used to diagnose

play11:31

sickle cell disease and usually it's

play11:33

either with a cellulose acetate or

play11:35

citrate agar gel and if you see more

play11:38

than 30% hemoglobin s in these patients

play11:42

then you can say okay these patients

play11:45

most likely have sickle cell disease so

play11:48

once we diagnose sickle cell disease how

play11:50

do we treat it well one of the main

play11:52

State treatments of sickle cell disease

play11:54

is hydroxyurea hydroxyurea can reduce

play11:58

episodes of acute pain it can reduce

play12:01

hospitalization rates and can prolong

play12:04

survival of patients with sickle cell

play12:06

disease another possible treatment is

play12:09

matoke we dick cell transplantation this

play12:12

is thought to be usually thought to be

play12:15

the only cure for sickle cell disease

play12:17

and it's usually performed only in

play12:20

individuals less than 16 years old and

play12:23

blood transfusion can be performed in

play12:26

patients with sickle cell disease

play12:27

because especially in patients with

play12:30

severe anemia if they have very low

play12:31

hemoglobin and because of many of the

play12:37

symptoms I've mentioned before due to

play12:39

vaso occlusion and pain management is

play12:43

very important in patients with sickle

play12:44

cell disease as well anyways guys that

play12:47

was a lesson on sickle cell disease I

play12:49

hope you found this video helpful if you

play12:50

did please like and subscribe for more

play12:51

videos like this one and as always thank

play12:53

you so much for watching and I'll see

play12:54

you next time

Rate This

5.0 / 5 (0 votes)

Связанные теги
Sickle CellBlood DisorderGenetic MutationHemoglobinAnemiaHydroxyureaTreatment OptionsVaso-occlusionInheritanceChronic Disease
Вам нужно краткое изложение на английском?